FTSE All-Share
5.329,48
PKT
+28,09
PKT
+0,53
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.04.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 27.04.12 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
| 27.04.12 | Barclays hold | Société Générale Group S.A. (SG) | |
| 27.04.12 | Unilever halten | Independent Research GmbH | |
| 26.04.12 | Shell (ex Royal Dutch Shell) buy | ING | |
| 26.04.12 | Shell (ex Royal Dutch Shell) halten | Independent Research GmbH | |
| 26.04.12 | Glencore buy | UBS AG | |
| 26.04.12 | Rio Tinto buy | UBS AG | |
| 26.04.12 | Anglo American buy | UBS AG | |
| 26.04.12 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 26.04.12 | GSK neutral | Sarasin Research | |
| 26.04.12 | Shell (ex Royal Dutch Shell) kaufen | National-Bank AG | |
| 26.04.12 | Unilever hold | ING | |
| 25.04.12 | Rio Tinto overweight | HSBC | |
| 25.04.12 | Anglo American overweight | HSBC | |
| 25.04.12 | Glencore overweight | HSBC | |
| 25.04.12 | Anglo American buy | UBS AG | |
| 25.04.12 | Shell (ex Royal Dutch Shell) buy | Sarasin Research | |
| 25.04.12 | Associated British Foods buy | Nomura | |
| 25.04.12 | Anglo American buy | Sarasin Research | |
| 25.04.12 | Shell (ex Royal Dutch Shell) outperform | Exane-BNP Paribas SA | |
| 25.04.12 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 24.04.12 | Vodafone Group overweight | HSBC | |
| 24.04.12 | Vodafone Group outperform | Sanford C. Bernstein and Co., Inc. | |
| 24.04.12 | Imperial Brands neutral | Banc of America Securities-Merrill Lynch | |
| 24.04.12 | BAT neutral | Banc of America Securities-Merrill Lynch | |
| 24.04.12 | Unilever neutral | UBS AG | |
| 24.04.12 | Shell (ex Royal Dutch Shell) buy | ING | |
| 24.04.12 | Persimmon buy | UBS AG | |
| 24.04.12 | Rio Tinto buy | Deutsche Bank AG | |
| 24.04.12 | Barclays buy | Deutsche Bank AG | |
| 24.04.12 | Vodafone Group kaufen | National-Bank AG | |
| 23.04.12 | Anglo American outperform | RBC Capital Markets | |
| 23.04.12 | AstraZeneca reduce | Nomura | |
| 23.04.12 | GSK neutral | Nomura | |
| 23.04.12 | Vodafone Group overweight | Morgan Stanley | |
| 23.04.12 | Vodafone Group buy | ING | |
| 23.04.12 | BP overweight | J.P. Morgan Cazenove | |
| 23.04.12 | BP hold | Société Générale Group S.A. (SG) | |
| 23.04.12 | BAT hold | Société Générale Group S.A. (SG) |